Went Gregory T
Insider CIK 1604541 · ADMS Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2019-04-08 | 2019-04-10 | 112,500 | — | $0 | 112,500 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2019-04-08 | 2019-04-10 | 56,250 | — | $0 | 232,541 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2019-03-20 | 2019-03-21 | 6,319 | $7.99 | $50.5K | 176,291 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | P Buy | 2018-11-07 | 2018-11-08 | 3,850 | $12.98 | $50.0K | 199,242 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2018-03-21 | 2018-03-22 | 4,541 | $25.75 | $116.9K | 182,610 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2018-03-06 | 2018-03-09 | 123,750 | — | $0 | 123,750 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2018-03-06 | 2018-03-09 | 20,625 | — | $0 | 187,151 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2017-03-21 | 2017-03-22 | 2,807 | $17.03 | $47.8K | 166,526 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2017-02-21 | 2017-02-23 | 138,750 | — | $0 | 138,750 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2017-02-21 | 2017-02-23 | 23,125 | — | $0 | 169,333 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | J Other deriv | 2016-10-05 | 2016-10-07 | 121,784 | — | $0 | 128,216 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | J Other deriv | 2016-10-05 | 2016-10-07 | 27,995 | — | $0 | 32,005 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | J Other deriv | 2016-10-05 | 2016-10-07 | 262,963 | — | $0 | 605,037 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | J Other deriv | 2016-10-05 | 2016-10-07 | 9,439 | — | $0 | 65,561 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | J Other | 2016-10-05 | 2016-10-07 | 117,450 | — | $0 | 146,208 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | J Other | 2016-10-05 | 2016-10-07 | 195,400 | — | $0 | 195,392 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2016-06-15 | 2017-02-23 | 204,900 | $1.88 | $385.2K | 263,658 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2016-06-15 | 2016-06-16 | 204,900 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2016-06-15 | 2016-06-16 | 204,900 | $1.88 | $385.2K | 263,658 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2016-03-04 | 2016-03-08 | 172,500 | — | $0 | 172,500 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2016-03-04 | 2016-03-08 | 28,750 | $13.66 | $392.7K | 58,758 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-05-14 | 2015-05-14 | 100 | — | $0 | 214,900 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-05-14 | 2015-05-14 | 100 | $18.00 | $1.8K | 30,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-05-14 | 2015-05-14 | 200 | $18.00 | $3.6K | 390,792 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-05-14 | 2015-05-14 | 100 | $1.88 | $188 | 30,108 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-05-13 | 2015-05-14 | 10,028 | — | $0 | 215,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-05-13 | 2015-05-14 | 10,028 | $1.88 | $18.9K | 30,036 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-05-13 | 2015-05-14 | 28 | $18.00 | $504 | 30,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-05-13 | 2015-05-14 | 100 | $18.00 | $1.8K | 390,992 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-05-12 | 2015-05-14 | 500 | — | $0 | 225,028 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-05-12 | 2015-05-14 | 500 | $1.88 | $940 | 20,508 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-05-12 | 2015-05-14 | 500 | $18.01 | $9.0K | 20,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-05-12 | 2015-05-14 | 1,800 | $18.00 | $32.4K | 391,092 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-04-23 | 2015-04-27 | 900 | — | $0 | 225,528 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-23 | 2015-04-27 | 900 | $18.00 | $16.2K | 20,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-23 | 2015-04-27 | 2,400 | $18.01 | $43.2K | 392,892 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-04-23 | 2015-04-27 | 900 | $1.88 | $1.7K | 20,908 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-04-21 | 2015-04-22 | 962 | — | $0 | 226,428 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-21 | 2015-04-22 | 962 | $18.01 | $17.3K | 20,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-04-21 | 2015-04-22 | 962 | $1.88 | $1.8K | 20,970 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-21 | 2015-04-22 | 1,811 | $18.00 | $32.6K | 395,292 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-04-20 | 2015-04-22 | 2,610 | — | $0 | 227,390 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-20 | 2015-04-22 | 5,200 | $18.00 | $93.6K | 397,103 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-20 | 2015-04-22 | 2,610 | $18.00 | $47.0K | 20,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-04-20 | 2015-04-22 | 2,610 | $1.88 | $4.9K | 22,618 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-04-14 | 2015-04-14 | 10,000 | — | $0 | 220,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-04-14 | 2015-04-14 | 80 | — | $0 | 230,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-14 | 2015-04-14 | 80 | $18.00 | $1.4K | 10,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-14 | 2015-04-14 | 100 | $18.00 | $1.8K | 402,303 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-04-14 | 2015-04-14 | 80 | $1.88 | $150 | 10,088 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-14 | 2015-04-14 | 10,000 | $1.88 | $18.8K | 20,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-04-10 | 2015-04-14 | 1,000 | — | $0 | 230,080 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-04-10 | 2015-04-14 | 1,000 | $1.88 | $1.9K | 11,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-10 | 2015-04-14 | 100 | $19.00 | $1.9K | 10,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-10 | 2015-04-14 | 3,077 | $18.16 | $55.9K | 402,903 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-10 | 2015-04-14 | 500 | $19.07 | $9.5K | 402,403 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-10 | 2015-04-14 | 900 | $18.09 | $16.3K | 10,108 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-03-20 | 2015-03-24 | 100 | — | $0 | 231,080 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-20 | 2015-03-24 | 200 | $18.00 | $3.6K | 405,980 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-20 | 2015-03-24 | 100 | $18.00 | $1.8K | 10,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-03-20 | 2015-03-24 | 100 | $1.88 | $188 | 10,108 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-03-19 | 2015-03-19 | 12,320 | — | $0 | 231,180 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-03-19 | 2015-03-19 | 12,320 | $1.88 | $23.2K | 12,328 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-19 | 2015-03-19 | 2,148 | $18.00 | $38.7K | 406,180 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-19 | 2015-03-19 | 2,320 | $18.00 | $41.8K | 10,008 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-03-18 | 2015-03-19 | 4,600 | — | $0 | 243,500 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-03-18 | 2015-03-19 | 4,600 | $1.88 | $8.6K | 4,608 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-18 | 2015-03-19 | 4,600 | $18.00 | $82.8K | 8 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-18 | 2015-03-19 | 9,420 | $18.00 | $169.6K | 408,328 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-03-17 | 2015-03-19 | 1,900 | — | $0 | 248,100 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-03-17 | 2015-03-19 | 1,900 | $1.88 | $3.6K | 1,908 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-17 | 2015-03-19 | 1,900 | $18.00 | $34.2K | 8 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-17 | 2015-03-19 | 2,700 | $18.00 | $48.6K | 417,748 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2015-02-25 | 2015-02-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-09-23 | 2014-09-24 | 23,110 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise | 2014-09-23 | 2014-09-24 | 23,110 | $4.50 | $104.0K | 420,448 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | C Conversion deriv | 2014-04-15 | 2014-04-16 | 8 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | C Conversion deriv | 2014-04-15 | 2014-04-16 | 6,674 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | C Conversion | 2014-04-15 | 2014-04-16 | 6,674 | — | $0 | 397,338 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | C Conversion | 2014-04-15 | 2014-04-16 | 8 | — | $0 | 8 | SEC↗ |